Total Payments
$49,304
2024 Payments
$49,082
Companies
5
Transactions
129
Medicare Patients
627
Medicare Billing
$88,952
Payment Breakdown by Category
Travel$20,103 (40.8%)
Other$17,300 (35.1%)
Consulting$8,394 (17.0%)
Food & Beverage$3,506 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $20,103 | 50 | 40.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,300 | 26 | 35.1% |
| Consulting Fee | $8,394 | 3 | 17.0% |
| Food and Beverage | $3,506 | 50 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $38,501 | 108 | $0 (2024) |
| Novo Nordisk Inc | $10,596 | 18 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $123.57 | 1 | $0 (2024) |
| VIVUS LLC | $65.24 | 1 | $0 (2022) |
| Rhythm Pharmaceuticals, Inc. | $17.96 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,082 | 125 | Lilly USA, LLC ($38,396) |
| 2023 | $156.01 | 3 | Lilly USA, LLC ($104.40) |
| 2022 | $65.24 | 1 | VIVUS LLC ($65.24) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $94.18 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $29.99 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $572.45 | General |
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $543.30 | General |
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $376.23 | General |
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $361.19 | General |
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $309.86 | General |
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $152.10 | General |
| 11/14/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $152.10 | General |
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $139.47 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $112.40 | General |
| 10/11/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Obesity | ||||||
| 10/11/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $987.35 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $774.70 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $427.04 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $427.04 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $369.59 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $363.78 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $363.78 | General |
| 10/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $176.73 | General |
| 10/09/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $124.77 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $7,031.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 23 | $9,476 | $2,073 |
| 2022 | 1 | 38 | 93 | $37,911 | $10,266 |
| 2021 | 3 | 100 | 154 | $60,556 | $17,175 |
| 2020 | 7 | 470 | 3,092 | $216,803 | $59,437 |
Total Patients
627
Total Services
3,362
Medicare Billing
$88,952
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 23 | $9,476 | $2,073 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 93 | $37,911 | $10,266 | 27.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 93 | $38,921 | $11,470 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 44 | $12,949 | $3,434 | 26.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $8,687 | $2,271 | 26.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 44 | 2,640 | $110,880 | $39,346 | 35.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 219 | 239 | $70,969 | $12,519 | 17.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 85 | 89 | $17,977 | $3,747 | 20.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 24 | $9,378 | $2,676 | 28.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 46 | 47 | $2,679 | $447.44 | 16.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 40 | 40 | $2,880 | $396.69 | 13.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 13 | 13 | $2,040 | $304.38 | 14.9% |
About Lori Wenz, NP
Lori Wenz, NP is a Family healthcare provider based in Grand Junction, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1679961783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lori Wenz, NP has received a total of $49,304 in payments from pharmaceutical and medical device companies, with $49,082 received in 2024. These payments were reported across 129 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($20,103).
As a Medicare-enrolled provider, Wenz has provided services to 627 Medicare beneficiaries, totaling 3,362 services with total Medicare billing of $88,952. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Grand Junction, CO
- Active Since 12/26/2014
- Last Updated 08/09/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679961783
Products in Payments
- ZEPBOUND (Drug) $17,151
- MOUNJARO (Drug) $800.00
- TALTZ (Drug) $264.24
- ZENPEP (Drug) $123.57
- Wegovy (Drug) $121.50
- QSYMIA (Drug) $65.24
- Imcivree (Drug) $17.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Grand Junction
April Ross, Np, NP
Family — Payments: $94,319
Family $94,319
Caroline Hendrix, Fnp-C, FNP-C
Family — Payments: $5,100
Family $5,100
Melinda Allen, Dnp, DNP
Family — Payments: $2,602
Family $2,602
Charlotte Chance, Fnp-Bc, FNP-BC
Family — Payments: $1,888
Family $1,888
Cathy Mccoy, Fnp-Bc, Pmhnp-Bc, FNP-BC, PMHNP-BC
Family — Payments: $1,680
Family $1,680
Ona Ridgway, Np, NP
Family — Payments: $1,421
Family $1,421